Skin cancer could twice as prevalent as previous estimations, as new
research shows that cases of basal cell carcinomas (BCCs) – the most
common kind of skin cancer – have soared by an incredible 80% in the
last decade. In addition, skin cancer rates are now almost on par with
every other type of cancer combined.
Non-melanoma basal cell carcinomas are abnormal, uncontrolled growths
that develop in the skin’s basal cells and often appear as painful
looking open sores with red patches, pink growths, shiny bumps, or
scars. BCCs mainly occur in fairer skinned people.
Although a family
history of the cancer is sometimes evident, for two thirds of patients
who develop BCC, overexposure to UV light either from the sun or
excessive use of sunbeds is usually the main factor behind it. Just in
the UK alone, the NHS previously estimated 100,000 new cases of
non-melanoma skin cancer diagnosed every year, and things could be
getting worse according to the new research and cases are actually
around the 200,000 mark.
The study, conducted by Norfolk and
Norwich University Hospitals NHS Foundation Trust and Eastern Cancer
Registration Centre in Cambridge, suggests a massive financial burden
being inflicted onto the NHS as it is believed each case costs about
£1,000 for treatment – resulting in excess of £200 million being drained
from an already tight NHS budget. On the positive side however, success
rates for basal cell carcinoma is incredible high and stands at
approximately 90%.
For cases of non-melanoma skin cancer such as BCC, surgery is the
main treatment undertaken. A surgeon will remove the cancerous tumour
and an area of the surrounding healthy tissue to make sure the cancer
has been properly removed. Scarring is the main risk with surgery and
often skin from a part of your body that is not always visible (i.e. the
back) is removed and ‘grafted’ to the affected area. Other treatment
options for non-melanoma skin cancer are: cryotherapy, creams,
radiotherapy, chemotherapy and a treatment known as photodynamic therapy
(PDT) whereby cream is applied to the affected area and a strong light
is shone onto it, killing the cancer in the process.
The team from East Anglia analysed data extracted from the eastern
registry deduce patterns of skin cancer incidence over an 11-year time
period and found that the number of patients requiring surgery for BCC
rose by 81%. After extrapolating the findings to the UK population, the
team came to the conclusion that around 200,000 patients had 247,000
cases of BCC treated surgically.
“Our study shows that the number of basal cell carcinomas (BCC) in
the UK is approximately twice that indicated by government statistics,”
said doctors from Norfolk and Norwich University Hospital NHS Foundation
Trust and Eastern Cancer Registration Centre, Cambridge. “The effects
on population health and on costs to the health services of BCC in the
UK should be recognised.
Resources to prevent, diagnose and manage the
disease should be prioritised to help control BCC, which now appears to
be the commonest malignant disease in the UK. Cancer registries
acknowledge that data collection for BCC is imperfect, and consequently
data on BCC are excluded from national statistics. Unfortunately, this
means that the commonest cancer in the UK is often overlooked by
politicians, the public and the media.”
Catherine Thomson, of Cancer Research UK, added: “Basal cell
carcinoma is the most common type of skin cancer and we need to find
better ways of recording the number of people diagnosed with it. This
means they are not routinely reported and the true workload and
treatment burden on the NHS is not widely understood. The good news is
that generally it’s one of the easiest forms of cancer to treat and it
is rarely fatal.”
Skin cancers are broadly divided into two types- Melanoma and non-melanoma. Melanoma is the most deadly of skin cancers.
ReplyDeleteSkin Cancer Therapy
Nice post. I read your post. It’s very simple and informatics. Thank you for sharing..............
ReplyDeleteSquamous Cell Skin Cancer